Sun Pharmaceutical Industries will buy U.S. drugmaker Organon & Co in an all-cash deal valued at about $11.75 billion ...
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG ("Araris") today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) ...
That's when its first-quarter results will be published.
With the purchase of Organon & Co., billionaire Dilip Shanghvi's Sun Pharmaceutical Industries' annual revenue will more than ...
By Puyaan Singh April 27 (Reuters) - Ligand Pharmaceuticals will buy fellow biotechnology royalty aggregator XOMA Royalty for ...
Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...
Sun Pharma to acquire Organon in a $12B deal, expanding global reach and strengthening its specialty drug portfolio.
Eli Lilly and Company (NYSE:LLY) is among the 15 Best Big Name Stocks to Buy. On April 21, Barclays analyst Emily Field ...
In this week’s edition of InnovationRx, we look at the first robotic cataract surgeries in humans, the underbelly of marketing compounded GLP-1s, and more.
Ligand Pharmaceuticals will buy fellow biotechnology royalty aggregator XOMA Royalty for about $739 million in cash, the companies said on Monday. The deal adds more than 120 treatments, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results